Key indices extended losses and hit fresh intraday low in mid-morning trade. At 11:21 IST, the barometer index, the S&P BSE Sensex, was down 116.05 points or 0.30% at 38,574.05. The Nifty 50 index was down 25.10 points or 0.21% at 11,651.70. Negative global cues spoiled investors sentiment.
The indices opened lower, but bounced back in early trade. Indices once again slipped into negative terrain in morning trade and hit fresh intraday low in mid-morning trade. The Sensex rose 148.35 points, or 0.38% at the day's high of 38,838.45 in early trade. The index fell 123.29 points, or 0.32% at the day's low of 38,566.81 in mid-morning trade. The Nifty rose 50.85 points, or 0.44% at the day's high of 11,727.65 in early trade. The index fell 33.60 points, or 0.29% at the day's low of 11,643.20 in mid-morning trade.
Among secondary barometers, the BSE Mid-Cap index was down 0.15%. The BSE Small-Cap index was up 0.02%. Both these indices outperformed the Sensex.
The market breadth, indicating the overall health of the market, was positive. On BSE, 1174 shares rose and 1125 shares fell. A total of 156 shares were unchanged.
YES Bank was down 5.86%. The bank announced after market hours on Thursday, 30 August 2018, that it has received the Reserve Bank of India's (RBI's) approval for the continuance of Rana Kapoor as managing director and CEO of the bank till further notice from the central bank.
Most IT shares rose. HCL Technologies (up 3.23%), Tech Mahindra (up 2.53%), MindTree (up 2.01%), Wipro (up 1.89%), Infosys (up 1.34%), Hexaware Technologies (up 1.19%) and TCS (up 0.10%), edged higher. Oracle Financial Services Software (down 0.22%), MphasiS (down 0.47%) and Persistent Systems (down 2.1%), edged lower.
Pharmaceutical shares rose across the board. Piramal Enterprises (up 4.09%), Cadila Healthcare (up 3.91%), Aurobindo Pharma (up 2.75%), Sun Pharmaceutical Industries (up 2.18%), Dr Reddy's Laboratories (up 2.02%), Lupin (up 1.81%), Cipla (up 1.65%), IPCA Laboratories (up 1.15%), Wockhardt (up 0.82%), Glenmark Pharmaceuticals (up 0.78%), Divi's Laboratories (up 0.74%), Alkem Laboratories (up 0.70%), GlaxoSmithKline Pharmaceuticals (up 0.53%) and Strides Shasun (up 0.46%), edged higher.
Overseas, Asia shares declined as Wall Street ended its four-day winning streak in the last session, following a report that US President Donald Trump voiced his support for moving forward with more proposed tariffs.
China reported on Friday that factory activity was higher than expected in August, with the official manufacturing Purchasing Manager's Index (PMI) coming in at 51.3. A reading above 50 indicates expansion, while a reading below that signals contraction. China's official services PMI for August rose to 54.2 for August against 54.0 in July, the National Bureau of Statistics reported.
In US, stocks snapped a four-day winning streak to finish lower Thursday, with the Dow falling back below 26,000. Media reported that Trump said to his aides that he supports going ahead with the imposition of proposed tariffs on an additional $200 billion in Chinese goods. The report did, however, also mention that Trump has not made up his mind on the matter. The White House declined to comment on the report.
On the US data front, initial jobless claims, a barometer of layoffs, rose by 3,000 to 213,000 in the week ended 25 August 2018. Nonetheless, the monthly average of claims fell by 1,500 to 212,250, the lowest level since December 1969.
Consumer spending climbed 0.4% in July, according to a government reading. Incomes rose 0.3%. And the 12-month increase in the PCE index, the Federal Reserve's preferred inflation gauge, rose to 2.3% from 2.2%, marking the highest level since April 2012, suggesting the Fed is likely to maintain its hawkish bias.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
